Q1 2015 Holdings
Filed 2015-05-15 | 130 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $667.5M | 20,481,442 | 47.4% |
| Biomarin Pharmaceuticals Inc.(BMRN) | COM | 09061G101 | $523.5M | 4,200,456 | 37.2% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $94.6M | 10,478,204 | 6.7% |
| Cerus Corp.(CERS) | COM | 157085101 | $56.5M | 13,553,275 | 4.0% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $32.8M | 7,565,462 | 2.3% |
| Agios Pharmaceuticals Inc.(AGIO) | COM | 00847X104 | $14.1M | 149,954 | 1.0% |
| Aurinia Pharmaceuticals, Inc.(AUPH) | COM | 05156V102 | $3.1M | 711,499 | 0.2% |
| Pharmacyclics Inc. | COM | 716933106 | $2.3M | 9,039,652 | 0.2% |
| Ascendis Pharma SA(ASND) | SPONSORED ADR | 04351P101 | $1.7M | 100,000 | 0.1% |
| Cellectis SA(CLLS) | SPONSORED ADR | 15117K103 | $1.7M | 50,000 | 0.1% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $1.4M | 142,000 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $1.4M | 14,845,559 | 0.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $1.2M | 11,340 | 0.1% |
| Synageva Biopharma Corp. | COM | 87159A103 | $1.1M | 11,660,432 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $1.0M | 28,876,712 | 0.1% |
| Salix Pharmaceuticals Inc. 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $801.2K | $216,077,000 | 0.1% |
| Incyte Corp. Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | $508.4K | $274,500,000 | 0.0% |
| Incyte Corp. Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | $471.9K | $259,000,000 | 0.0% |
| Incyte Corp. Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | $421.7K | $40,446,000 | 0.0% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $417.2K | 13,656,942 | 0.0% |
| Anacor Pharmaceuticals Inc. | COM | 032420101 | $243.2K | 4,204,702 | 0.0% |
| Biomarin Pharmaceuticals Inc. Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $137.0K | $22,379,000 | 0.0% |
| Invitae Corp.(NVTA1EUR) | COM | 46185L103 | $109.9K | 6,554,967 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $102.9K | 1,327,451 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $100.9K | 6,021,485 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $97.1K | 4,190,594 | 0.0% |
| Gilead Sciences Inc. 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $90.2K | $20,944,000 | 0.0% |
| Medivation Inc. 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $84.9K | $33,889,000 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $82.2K | 2,805,074 | 0.0% |
| Acorda Therapeutics Inc. Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | $60.8K | $59,583,000 | 0.0% |
| Versartis Inc. | COM | 92529L102 | $54.7K | 2,977,396 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $53.5K | 14,708,613 | 0.0% |
| Xenoport Inc. | COM | 98411C100 | $46.3K | 6,508,622 | 0.0% |
| Array Biopharma Inc.(ARRYEUR) | COM | 04269X105 | $41.7K | 5,658,755 | 0.0% |
| Salix Pharmaceuticals Inc. 1.5% 3/15/19 | CONV BONDS | 795435AE6 | $38.9K | $14,668,000 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $37.9K | 2,607,784 | 0.0% |
| DBV Technologies Inc. | SPONSORED ADR | 23306J101 | $35.5K | 1,519,229 | 0.0% |
| Insmed Inc.(INSM) | COM | 457669307 | $32.9K | 1,583,490 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $32.1K | 2,248,152 | 0.0% |
| TG Therapeutics Inc.(TGTX) | COM | 88322Q108 | $31.7K | 2,050,313 | 0.0% |
| Derma Sciences Inc. | COM | 249827502 | $29.3K | 3,457,841 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $26.0K | 4,350,808 | 0.0% |
| Idera Pharmaceuticals Inc. | COM | 45168K306 | $25.8K | 6,965,432 | 0.0% |
| Alder Biopharmaceuticals Inc.(ALDR1EUR) | COM | 014339105 | $25.4K | 879,581 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $24.6K | 738,916 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $24.5K | 249,995 | 0.0% |
| Sangamo Biosciences, Inc.(SGMO) | COM | 800677106 | $22.0K | 1,404,544 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $21.5K | 542,236 | 0.0% |
| Biomarin Pharmaceuticals Inc. Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | $18.0K | $12,228,000 | 0.0% |
| Kythera Biopharmaceuticals Inc. | COM | 501570105 | $17.8K | 354,265 | 0.0% |